We want you to feel inspired every day. We’re future-focused and our business is growing. We succeed together through passion, commitment and teamwork, and so can you. We are currently recruiting for a Principal Software Developer to join the Data Science and Software Development team. The purpose of this role is to design, develop, and maintain software applications that meet the needs of our business and work closely with all teams within OXB to enable digital transformation. Our team interfaces with all areas of the business to provide day to day support, ensuring operational effectiveness for all employees. They look for innovative solutions to protect and meet the businesses digitisation needs. Your responsibilities in this role would be: • Collaborate with business teams to support the rollout, implementation, and adoption of various digital initiatives and platforms within OXB. • Lead the technical design, development, and implementation of complex software applications and solutions, providing architectural input and taking ownership of significant modules or components. • Evaluate existing software systems and processes, recommending improvements and overseeing the implementation of changes to drive efficiency and performance. Help implement improved laboratory processes/workflows including lab automation efforts. • Mentor and guide junior developers in the adoption and implementation of digital initiatives and platforms, ensuring that they understand and follow company guidelines and standards. Lead code review sessions and promote a culture of high-quality software engineering. • Plan, design, and oversee the creation of data pipelines and the integration of third-party tools and APIs, ensuring system stability, scalability, and performance. Propose proofs of concepts (POCs) for innovative software solutions, enabling strategic decisions regarding feasibility and potential benefits. • Present technical concepts and solutions to stakeholders, demonstrating the ability to communicate complex ideas effectively to both technical and non-technical audiences. • Take ownership of digital transformation efforts across all platform processes, ensuring alignment and consistency across multiple sites while maintaining a global perspective to drive cohesive, company-wide innovation. We are looking for: • Expertise in seamlessly integrating third-party software, platforms, and APIs into proprietary applications, ensuring optimal performance and scalability. • While this role involves coding in Python and working with SQL, candidates with a strong foundation in relevant programming languages and frameworks are welcome to apply. • Experience with implementing or customizing ELNs, LIMS, or any similar mid- to large-scale database-backed application with APIs is preferred, but not strictly required. • Extensive experience with version control tools like Git and project management platforms like JIRA, with a focus on optimizing workflows and ensuring smooth collaboration across teams. • Deep understanding of software development life cycles, methodologies, and principles. Proven ability to design, code, test, and deploy complex software applications, ensuring high-quality deliverables. • Advanced skills in handling, processing, and optimizing large datasets, with a deep understanding of data storage, retrieval, transformation, and ensuring data integrity at scale. • A passion for exploring new technologies and a willingness to continually learn and apply innovative solutions is highly valued. About Us: OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise. What’s in it for you: • Highly competitive total reward packages • Wellbeing programmes • Development opportunities • Welcoming, friendly, supportive colleagues • A diverse and inclusive working environment • Our values are: Responsible, Responsive, Resilient, Respect • State of the art laboratory and manufacturing facilities We want you to feel inspired every day. We’re future-focused and our business is growing rapidly. We succeed together through passion, commitment and teamwork, and so can you. Collaborate. Contribute. Change lives Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies. Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy). Oxford Biomedica collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.